294 related articles for article (PubMed ID: 21886855)
1. The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing.
Diaz-Gonzalez R; Kuhlmann FM; Galan-Rodriguez C; Madeira da Silva L; Saldivia M; Karver CE; Rodriguez A; Beverley SM; Navarro M; Pollastri MP
PLoS Negl Trop Dis; 2011 Aug; 5(8):e1297. PubMed ID: 21886855
[TBL] [Abstract][Full Text] [Related]
2. In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against
Phan TN; Baek KH; Lee N; Byun SY; Shum D; No JH
Molecules; 2020 Apr; 25(8):. PubMed ID: 32340370
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a structure-activity relationship of 1H-imidazo[4,5-c]quinoline-based kinase inhibitor NVP-BEZ235 as a lead for African sleeping sickness.
Seixas JD; Luengo-Arratta SA; Diaz R; Saldivia M; Rojas-Barros DI; Manzano P; Gonzalez S; Berlanga M; Smith TK; Navarro M; Pollastri MP
J Med Chem; 2014 Jun; 57(11):4834-48. PubMed ID: 24805946
[TBL] [Abstract][Full Text] [Related]
4. 2,4-Diaminopyrimidines as potent inhibitors of Trypanosoma brucei and identification of molecular targets by a chemical proteomics approach.
Mercer L; Bowling T; Perales J; Freeman J; Nguyen T; Bacchi C; Yarlett N; Don R; Jacobs R; Nare B
PLoS Negl Trop Dis; 2011 Feb; 5(2):e956. PubMed ID: 21347454
[TBL] [Abstract][Full Text] [Related]
5. Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis.
Lorente SO; Rodrigues JC; Jiménez Jiménez C; Joyce-Menekse M; Rodrigues C; Croft SL; Yardley V; de Luca-Fradley K; Ruiz-Pérez LM; Urbina J; de Souza W; González Pacanowska D; Gilbert IH
Antimicrob Agents Chemother; 2004 Aug; 48(8):2937-50. PubMed ID: 15273104
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
[TBL] [Abstract][Full Text] [Related]
7. Targeting the HSP60/10 chaperonin systems of Trypanosoma brucei as a strategy for treating African sleeping sickness.
Abdeen S; Salim N; Mammadova N; Summers CM; Goldsmith-Pestana K; McMahon-Pratt D; Schultz PG; Horwich AL; Chapman E; Johnson SM
Bioorg Med Chem Lett; 2016 Nov; 26(21):5247-5253. PubMed ID: 27720295
[TBL] [Abstract][Full Text] [Related]
8. Screening a Natural Product-Based Library against Kinetoplastid Parasites.
Zulfiqar B; Jones AJ; Sykes ML; Shelper TB; Davis RA; Avery VM
Molecules; 2017 Oct; 22(10):. PubMed ID: 29023425
[TBL] [Abstract][Full Text] [Related]
9. The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp.
Scarim CB; Chelucci RC; Dos Santos JL; Chin CM
Med Chem; 2020; 16(1):24-38. PubMed ID: 31218962
[TBL] [Abstract][Full Text] [Related]
10. 8,8-dialkyldihydroberberines with potent antiprotozoal activity.
Endeshaw M; Zhu X; He S; Pandharkar T; Cason E; Mahasenan KV; Agarwal H; Li C; Munde M; Wilson WD; Bahar M; Doskotch RW; Kinghorn AD; Kaiser M; Brun R; Drew ME; Werbovetz KA
J Nat Prod; 2013 Mar; 76(3):311-5. PubMed ID: 23167812
[TBL] [Abstract][Full Text] [Related]
11. Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites.
Engel JA; Jones AJ; Avery VM; Sumanadasa SD; Ng SS; Fairlie DP; Skinner-Adams T; Andrews KT
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):117-26. PubMed ID: 26199860
[TBL] [Abstract][Full Text] [Related]
12. Anti-Trypanosomatid Elemanolide Sesquiterpene Lactones from Vernonia lasiopus O. Hoffm.
Kimani NM; Matasyoh JC; Kaiser M; Brun R; Schmidt TJ
Molecules; 2017 Apr; 22(4):. PubMed ID: 28397756
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi.
Parsons M; Worthey EA; Ward PN; Mottram JC
BMC Genomics; 2005 Sep; 6():127. PubMed ID: 16164760
[TBL] [Abstract][Full Text] [Related]
14. Squalamine analogues as potential anti-trypanosomal and anti-leishmanial compounds.
Khabnadideh S; Tan CL; Croft SL; Kendrick H; Yardley V; Gilbert IH
Bioorg Med Chem Lett; 2000 Jun; 10(11):1237-9. PubMed ID: 10866389
[TBL] [Abstract][Full Text] [Related]
15. Quinoxaline derivatives as potential antitrypanosomal and antileishmanial agents.
Cogo J; Cantizani J; Cotillo I; Sangi DP; Corrêa AG; Ueda-Nakamura T; Filho BPD; Martín JJ; Nakamura CV
Bioorg Med Chem; 2018 Aug; 26(14):4065-4072. PubMed ID: 30100019
[TBL] [Abstract][Full Text] [Related]
16. Potent antiprotozoal activity of a novel semi-synthetic berberine derivative.
Bahar M; Deng Y; Zhu X; He S; Pandharkar T; Drew ME; Navarro-Vázquez A; Anklin C; Gil RR; Doskotch RW; Werbovetz KA; Kinghorn AD
Bioorg Med Chem Lett; 2011 May; 21(9):2606-10. PubMed ID: 21474310
[TBL] [Abstract][Full Text] [Related]
17. Protein farnesyltransferase from Trypanosoma brucei. A heterodimer of 61- and 65-kda subunits as a new target for antiparasite therapeutics.
Yokoyama K; Trobridge P; Buckner FS; Van Voorhis WC; Stuart KD; Gelb MH
J Biol Chem; 1998 Oct; 273(41):26497-505. PubMed ID: 9756885
[TBL] [Abstract][Full Text] [Related]
18. Anilinoquinoline based inhibitors of trypanosomatid proliferation.
Ferrins L; Sharma A; Thomas SM; Mehta N; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Gillingwater K; Pollastri MP
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006834. PubMed ID: 30475800
[TBL] [Abstract][Full Text] [Related]
19. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
[TBL] [Abstract][Full Text] [Related]
20. Chalcone, acyl hydrazide, and related amides kill cultured Trypanosoma brucei brucei.
Troeberg L; Chen X; Flaherty TM; Morty RE; Cheng M; Hua H; Springer C; McKerrow JH; Kenyon GL; Lonsdale-Eccles JD; Coetzer TH; Cohen FE
Mol Med; 2000 Aug; 6(8):660-9. PubMed ID: 11055585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
